China Dna Diagnostics Market Size & Outlook, 2024-2030
China dna diagnostics market, 2018-2030 (US$M)
China dna diagnostics market highlights
- The China dna diagnostics market generated a revenue of USD 851.8 million in 2023 and is expected to reach USD 1,317.4 million by 2030.
- The China market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2023.
- NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.
Dna diagnostics market data book summary
| Market revenue in 2023 | USD 851.8 million |
| Market revenue in 2030 | USD 1,317.4 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Pcr-based diagnostics |
| Fastest growing segment | NGS DNA Diagnosis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
Other key industry trends
- In terms of revenue, China accounted for 8.0% of the global dna diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan dna diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,317.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Diagnostics Market Scope
DNA Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China dna diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 49.68% in 2024. Horizon Databook has segmented the China dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
In China, there has been a significant shift in death rates over the past 40 years from infectious diseases to NCDs. DNA testing can identify pathogens with high precision, enabling rapid and accurate diagnosis of infections like bacterial, viral, & fungal diseases.
This helps in tailoring the right treatment quickly. The main causes of this change have been risk factors like nutrition, physical inactivity, and smoking. Due to socioeconomic progress and demographic changes, China has experienced significant shifts in its mortality patterns over the past 40 years, moving from infectious diseases to NCDs.
This shift has been fueled by the widespread nature of risk factors, such as alcohol misuse, smoking, poor food, and physical inactivity; as a result, the leading causes of mortality in this country are now diabetes, cancer, Cardiovascular Disease (CVD), and Chronic Respiratory Diseases (CRD).
Reasons to subscribe to China dna diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China dna diagnostics market databook
-
Our clientele includes a mix of dna diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into China dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China dna diagnostics market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
